Byline: Melissa Rohman
-
Inaugural LEAP Program Graduates its First Class of Emerging Faculty Leaders
The Northwestern University Leadership Education Advancement Program (NU-LEAP) welcomed its inaugural class of Feinberg faculty graduates during a virtual ceremony on April 13.
-
Feinberg Welcomes Admitted Students During Virtual Second Look
Admitted students recently attended this year’s virtual Second Look, a month-long series of online informational sessions about the medical school’s curriculum and community and opportunities to speak with current students and faculty.
-
Understanding Epigenetic Regulators in Neurodevelopmental Diseases and Cancer
Northwestern Medicine investigators are advancing the understanding of two groups of transcription factors and their role in many neurodevelopmental diseases and cancers, which is essential for developing novel therapeutic approaches.
-
Study Discovers Dual Function of Neutrophils in Cancer Cells
Northwestern Medicine investigators have discovered how a particular type of immune cell exerts a dual function in cancer cells that is contingent on tumor grade.
-
PPA Conference Builds Connections in the Aphasia Field
More than 350 participants attended the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease’s virtual PPA Conference, which featured keynote speakers and group support sessions focused on Primary Progressive Aphasia.
-
Protein Variant May Have Potential as Target for Glioblastoma
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a recent Northwestern Medicine study.
-
Feinberg Investigators Discuss Impact and Evolution of COVID-19
It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.
-
Northwestern Scientists Discover Potential Therapeutic Target for Glioblastoma
Northwestern Medicine investigators have discovered that inhibiting tumor-associated myeloid cells ability to produce specialized metabolites called polyamines may improve the effectiveness of treatments for glioblastoma.
-
Northwestern Medicine Scientists Track COVID-19 Variants
Since March 2020, a team of Northwestern Medicine scientists have been tracking the evolution of SARS- CoV-2, specifically in the city of Chicago. Their work has been pivotal in understanding how the virus spread to Chicago and what new variants have emerged in the city.
-
Medical Honor Society Welcomes 2021 Inductees
Forty-four new members were inducted into Northwestern’s chapter of the Alpha Omega Alpha medical honor society during a virtual ceremony on March 17.
